{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indianapolis",
      "state": "IN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80703",
      "recalling_firm": "Northwind Pharmaceuticals LLC",
      "address_1": "9402 Uptown Dr Ste 1100",
      "address_2": "",
      "postal_code": "46256-1042",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Indiana",
      "recall_number": "D-1098-2018",
      "product_description": "Valsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-0654-52",
      "product_quantity": "14 bottles",
      "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.",
      "recall_initiation_date": "20180718",
      "center_classification_date": "20180815",
      "termination_date": "20230325",
      "report_date": "20180822",
      "code_info": "Lot: UT48100001, exp 9/30/2019",
      "more_code_info": ""
    }
  ]
}